ENTRY       D11375                      Drug
NAME        Trastuzumab duocarmazine (USAN/INN)
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
              DG01917  Receptor tyrosine kinase inhibitor
               DG03158  HER2 inhibitor
REMARK      ATC code: L01FD05
EFFICACY    Antineoplastic, Alkylating agent, Receptor tyrosine kinase inhibitor, Anti-HER2 antibody
  TYPE      Antibody-drug conjugate
TARGET      ERBB2 (HER2, CD340) [HSA:2064] [KO:K05083]
            DNA
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
                L01FD HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
                 L01FD05 Trastuzumab duocarmazine
                  D11375  Trastuzumab duocarmazine (USAN/INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG03158  HER2 inhibitor
                 D11375  Trastuzumab duocarmazine
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               EGFR family
                ERBB2 (HER2, CD340)
                 D11375  Trastuzumab duocarmazine (USAN/INN)
DBLINKS     CAS: 1642152-40-6
            PubChem: 384585353
///
